151 related articles for article (PubMed ID: 35217485)
1. Temporal Incidence and Prevalence Trends of Multiple Sclerosis in Markazi Province, Iran.
Faraji F; Ahmadi F; Mohaghegh P; Talaie A
Mult Scler Relat Disord; 2022 Apr; 60():103691. PubMed ID: 35217485
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of familial multiple sclerosis and its comparison to sporadic form in Markazi Province, Iran.
Faraji F; Mohaghegh P; Talaie A
Mult Scler Relat Disord; 2022 Dec; 68():104231. PubMed ID: 36270251
[TBL] [Abstract][Full Text] [Related]
3. Temporal trends of incidence and prevalence of multiple sclerosis in Razavi Khorasan Province, Northeast Iran.
Sarmadi M; Saravani H; Azizi O; Najafi F; Hadei M; Momeni J; Bazrafshan E
Neurol Sci; 2022 Jan; 43(1):583-591. PubMed ID: 33939041
[TBL] [Abstract][Full Text] [Related]
4. Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?
Mohebi F; Eskandarieh S; Mansournia MA; Mohajer B; Sahraian MA
Arch Iran Med; 2019 Aug; 22(8):429-434. PubMed ID: 31679345
[TBL] [Abstract][Full Text] [Related]
5. Incidence Trend of Gastrointestinal Cancer in Markazi, in the Center of Iran, Population-Based Cancer Registry Results: 2010-2014.
Taheri M; Nazari J; Anoshirvani AA; Aghabozorgi R; Tabaeian SP; Bahrami M; Almasi-Hashiani A
J Gastrointest Cancer; 2021 Sep; 52(3):915-921. PubMed ID: 32901447
[TBL] [Abstract][Full Text] [Related]
6. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.
Elhami SR; Mohammad K; Sahraian MA; Eftekhar H
Neuroepidemiology; 2011; 36(3):141-7. PubMed ID: 21508646
[TBL] [Abstract][Full Text] [Related]
7. Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018.
Baghbanian SM; Cheraghmakani H; HabibiSaravi R; Azar A; Ghasemihamedani F
BMC Neurol; 2020 Feb; 20(1):52. PubMed ID: 32050931
[TBL] [Abstract][Full Text] [Related]
8. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.
Almasi-Hashiani A; Sahraian MA; Eskandarieh S
BMC Neurol; 2020 May; 20(1):169. PubMed ID: 32359352
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and incidence of multiple sclerosis in Isfahan, Iran between 1996 and 2021: A population-based study.
Barzegar M; Vaheb S; Mirmosayyeb O; Ashtari F; Afshari-Safavi A; Adibi I; Shaygannejad A; Mazaheri S; Rahimi M; Shaygannejad V
Mult Scler Relat Disord; 2024 Apr; 84():105479. PubMed ID: 38359695
[TBL] [Abstract][Full Text] [Related]
10. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
Etemadifar M; Maghzi AH
Mult Scler; 2011 Aug; 17(8):1022-7. PubMed ID: 21459809
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis incidence temporal trend in the Northeast of Iran: Using the Empirical Bayesian method.
Taghizadeh-Diva SE; Khosravi A; Zolfaghari S; Hosseinzadeh A
Mult Scler Relat Disord; 2023 Feb; 70():104469. PubMed ID: 36587485
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis in Isfahan, Iran.
Saadatnia M; Etemadifar M; Maghzi AH
Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
[TBL] [Abstract][Full Text] [Related]
13. Is the sharp increasing trend of multiple sclerosis incidence real in Iran?
Hosseinzadeh A; Sedighi B; Kermanchi J; Heidari M; Haghdoost AA
BMC Neurol; 2021 Jan; 21(1):7. PubMed ID: 33407243
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis incidence rate in southern Iran: a Bayesian epidemiological study.
Asmarian N; Sharafi Z; Mousavi A; Jacques R; Tamayo I; Bind MA; Abutorabi-Zarchi M; Moradian MJ; Izadi S
BMC Neurol; 2021 Aug; 21(1):309. PubMed ID: 34376167
[TBL] [Abstract][Full Text] [Related]
15. Ongoing increase in incidence and prevalence of multiple sclerosis in south-eastern Iran: A three decade study.
Moghtaderi A; Shahidi-Pourakbari M; Izadi S; Khosravi A; Hashemzehi Z
Mult Scler Relat Disord; 2023 Mar; 71():104557. PubMed ID: 36857854
[TBL] [Abstract][Full Text] [Related]
16. The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs.
Sharafaddinzadeh N; Moghtaderi A; Majdinasab N; Dahmardeh M; Kashipazha D; Shalbafan B
Clin Neurol Neurosurg; 2013 Aug; 115(8):1271-5. PubMed ID: 23273383
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series.
Amini P; Almasi-Hashiani A; Sahraian MA; Najafi M; Eskandarieh S
BMC Neurol; 2021 Jun; 21(1):235. PubMed ID: 34167483
[TBL] [Abstract][Full Text] [Related]
18. Age and sex-adjusted incidence and yearly prevalence of multiple sclerosis (MS) in Mazandaran province, Iran: An 11-years study.
Cheraghmakani H; Baghbanian SM; HabibiSaravi R; Azar A; Ghasemihamedani F
PLoS One; 2020; 15(7):e0235562. PubMed ID: 32614900
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of multiple sclerosis in Isfahan, Iran.
Etemadifar M; Janghorbani M; Shaygannejad V; Ashtari F
Neuroepidemiology; 2006; 27(1):39-44. PubMed ID: 16804333
[TBL] [Abstract][Full Text] [Related]
20. Age and sex adjusted prevalence and annual incidence of multiple sclerosis in East-Azerbaijan, Iran.
Talebi M; Sadigh-Eteghad S; Sahraian MA; Fahidi A
Mult Scler Relat Disord; 2021 May; 50():102839. PubMed ID: 33592381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
